ArticleDrug design, development and therapy2019

The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease.

Dan-Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.